Brendan Griffin is a Professor in Pharmaceutics at the University of College Cork (UCC) School of Pharmacy. He holds a BSc. Pharm. and PhD from Trinity College Dublin (TCD) and has extensive industry experience with Élan and Servier. As Course Director of the MSc in Pharmaceutical Technology and Quality Systems, he focuses on training pharmaceutical professionals to become Qualified Persons (QP). His research centers on optimized drug delivery systems, including lipid-based formulations, nanoparticulate systems, and targeted delivery to the brain and intestinal lymphatics. He leads the InPharma EU grant, an Industrial Doctorate program aiming to eliminate animal testing in formulation development by integrating computational and in vitro tools. His work emphasizes collaboration with industry and preclinical models like pigs to predict oral drug absorption and food effects. Education: BSc. Pharm. (TCD), PhD in Pharmaceutics (TCD). Research Interests: Lipid-based formulations for solubility enhancement and bioavailability Nanoparticulate drug delivery systems Targeted delivery mechanisms Computational models for drug development Regulatory science and quality-by-design approaches Pharmaceutical education and training InPharma Project: This EU Horizon 2020 initiative replaces animal testing with predictive in vitro and computational tools, linking drug discovery to clinical trial modeling. Key focus areas include end-to-end drug development and model-based design. Grants & Collaborations: Coordinates InPharma consortium involving academia and industry partners to advance drug formulation science. Labs/Teams: Associated with APC Microbiome Ireland and the School of Pharmacy’s Pharmaceutics division, focusing on interdisciplinary research in drug delivery and biopharmaceutics.












